Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Oncolution AB — Board member

Roles

AlzeCure Pharma AB Stockholm
Board member
30.06.2026 – 30.06.2026

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
30.06.2026AlzeCure Pharma AB Stockholm
New shares (subscription)
327,406SEK 1.31
SEK 428,901.86
↗